These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Severe hypertriglyceridemia associated with olanzapine. Stoner SC; Dubisar BM; Khan R; Farrar CD J Clin Psychiatry; 2002 Oct; 63(10):948-9. PubMed ID: 12416606 [No Abstract] [Full Text] [Related]
5. Weight gain and hyperglycaemia associated with olanzapine. Riccitelli G; Baker N Aust N Z J Psychiatry; 2002 Apr; 36(2):270-1. PubMed ID: 11982558 [No Abstract] [Full Text] [Related]
6. Olanzapine: weight gain and therapeutic efficacy. Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B J Clin Psychopharmacol; 1999 Jun; 19(3):273-5. PubMed ID: 10350036 [No Abstract] [Full Text] [Related]
7. Olanzapine-induced weight gain. Gupta S; Droney T; Al-Samarrai S; Keller P; Frank B Ann Clin Psychiatry; 1998 Mar; 10(1):39. PubMed ID: 9622049 [No Abstract] [Full Text] [Related]
8. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia. Levy E; Margolese HC; Chouinard G J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686 [No Abstract] [Full Text] [Related]
9. Effect of amantadine on weight gain during olanzapine treatment. Floris M; Lejeune J; Deberdt W Eur Neuropsychopharmacol; 2001 Apr; 11(2):181-2. PubMed ID: 11313165 [TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy. Gupta S; Steinmeyer C; Frank B; Madhusoodanan S; Lockwood K; Lentz B; Keller P Am J Ther; 2003; 10(5):348-55. PubMed ID: 12975719 [TBL] [Abstract][Full Text] [Related]
12. Novel antipsychotics and severe hyperlipidemia. Meyer JM J Clin Psychopharmacol; 2001 Aug; 21(4):369-74. PubMed ID: 11476120 [TBL] [Abstract][Full Text] [Related]
14. Olanzapine for schizophrenia. Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682 [No Abstract] [Full Text] [Related]
15. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report. Markham-Abedi C; de Leon J J Clin Psychiatry; 2006 Sep; 67(9):1473-4. PubMed ID: 17017841 [No Abstract] [Full Text] [Related]
16. Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study. Virkkunen M; Wahlbeck K; Rissanen A; Naukkarinen H; Franssila-Kallunki A Pharmacopsychiatry; 2002 May; 35(3):124-6. PubMed ID: 12107860 [TBL] [Abstract][Full Text] [Related]
17. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report. Malyuk R; Gibson B; Procyshyn RM; Kang N Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885 [TBL] [Abstract][Full Text] [Related]
18. [Type 2 diabetes and dyslipidemia. Side effects of "Atypical" neuroleptics?]. Wetterling T Med Klin (Munich); 2003 Jul; 98(7):364-7. PubMed ID: 12937901 [TBL] [Abstract][Full Text] [Related]
19. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. Selva KA; Scott SM J Pediatr; 2001 Jun; 138(6):936-8. PubMed ID: 11391346 [TBL] [Abstract][Full Text] [Related]
20. Profound hypertriglyceridemia and weight gain in the first week following initiation of olanzapine: a case report with implications for lipid monitoring guidelines. Kimmel RJ; Levy MR Psychosomatics; 2013; 54(4):392-4. PubMed ID: 23261075 [No Abstract] [Full Text] [Related] [Next] [New Search]